Alkermes Launches Phase 3 Program for Investigational Narcolepsy Therapy Alixorexton
- April 7, 2026
Can We Fix This Broken Heart? – Part 2
A New Hope for Treatment-Resistant Multiple Myeloma: CellCentric Advances InoPd into Pivotal Clinical Testing
Gilead Ends Midstage HIV Study as FDA Clinical Hold Continues
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Sotos syndrome is a rare genetic condition that affects growth and development, often leading to physical overgrowth in childhood along with developmental differences. Because it’s rare, many families may spend time searching for answers before receiving a diagnosis.
Raising awareness helps bring more understanding to conditions like Sotos syndrome and the individuals and families navigating them every day. By learning about rare diseases, we can help create a more informed, supportive community.
#SotosSyndrome #SotosSyndromeAwareness #RareDiseaseOfTheWeek #RareDiseaseAwareness #PatientWorthy
A New Hope for Treatment-Resistant Multiple Myeloma: CellCentric Advances InoPd into Pivotal Clinical Testing bit.ly/4slMlDA Read now at PatientWorthy.com
#PatientWorthy #multiplemyeloma #rrmm #clinicaltrials
Bohring-Optiz Syndrome (BOS) is a rare genetic disorder that impacts growth and development, often associated with feeding difficulties, developmental delays, and distinct physical characteristics. While uncommon, it has a profound impact on individuals and families within the BOS community.
Observed annually on April 6th, Bohring-Optiz Syndrome Awareness Day is dedicated to increasing understanding, supporting affected families, and advancing research. By raising awareness, we help foster greater recognition, compassion, and process toward improved care and outcomes.
Share your rare disease journey and inspire others here: bit.ly/4dV7gru
#bohring-OptizSyndrome #BOSAwarenessDay #PatientWorthy
